Metabolic Investigation, Physical Performance, Physical Training At Different Times of the Day in Obese Women (MOT-time)

December 9, 2024 updated by: Camila Fernanda Costa e Cunha Moraes Brandao, State University of Minas Gerais

Effect of Combined Physical Training At Different Times of the Day on Muscle and Adipose Tissue Remodeling, Metabolism and Physical Performance in Female Mice and Women with Obesity

Obesity is a disease characterized by the accumulation of adipose tissue, which is multifactorial and can be caused by environmental, social, behavioral, biological and genetic issues, and affects people health and well-being. In this sense, it is still difficult to maintain an effective treatment for obesity, since currently in Brazil, 24% of the population is obese and 61% is overweight. Physical exercise is considered a component that promotes numerous benefits to the human body, by releasing molecules through muscle contraction that will travel throughout the body as a whole, resulting in benefits such as increased energy expenditure and, consequently, improved physical performance, which will influence a person's daily activities. However, the effects of physical exercise depend on some factors, such as the time and duration of the practice. In addition, the changes that occur in the body can be influenced by the time of day. Likewise, it is known how important it is to maintain adequate sleep duration at night. It is possible that the time of day when exercise is practiced influences the responses that occur in the human body. To understand this fact, obese women will undergo combined physical training (strength and aerobic exercises) performed in the morning and evening. The aim is to better understand the time of day for controlling the metabolism of obese people. And, if there is a time when people perform better in daily activities.

Therefore, the objective of this clinical trial is to evaluate whether the time of day influences the responses to combined physical training in the modulation of energy metabolism and its biochemical markers in obese women. The main questions to be answered are:

  1. Can combined physical training (CPT) performed at night have different metabolic responses than CPT in the morning?
  2. Can cardiopulmonary and muscular strength performance have different magnitudes of responses to CPT performed at different times of the day?
  3. Can combined physical training (CPT) in the evening (NOT) compared to the morning (MAT) period cause more marked physiological adaptations, improving metabolic control in women with obesity?

Study Overview

Detailed Description

Obesity is a chronic, non-communicable, neuroendocrine and nutrimetabolic disease with multifactorial development, which results in a positive energy balance and excessive accumulation of adipose tissue. Characteristics of its metabolic profile include changes in mitochondrial architecture and in the secretion of hormones, such as insulin, which controls glucose metabolism. In obese individuals, adipocytes can undergo hypertrophy and hyperplasia processes, inducing low-grade inflammation. Conventional treatment for obesity consists of a hypocaloric diet combined with increased physical activity aimed at achieving a negative energy balance. However, the failure of these measures has highlighted the need for metabolic studies and studies of factors that may influence non-pharmacological treatments, such as physical training.

Physical training can improve the lipid profile of obesity, reducing cholesterol, trimethylamine N-oxide and sphingolipids, which are associated with risk factors for cardiovascular morbidity caused by obesity. An intervention with combined physical training (CPT) for 8 weeks can reduce waist circumference and increase maximum oxygen consumption in women with obesity. This approach can improve physiological functions that are altered due to obesity, such as hormonal control and bioenergetic efficiency, impacting physical fitness, regardless of weight loss. These improvements may arise depending on the configuration of the training load components, such as frequency, intensity, volume, repetition duration, pause and total session time, since it is a modifiable aspect and its manipulation provides different physiological responses.

In this sense, another factor to be considered is the circadian rhythm, which acts on metabolic regulation, and considering its functions it is assumed that it can influence the treatment of metabolic disorders, such as obesity, and physical performance. It is a biological event in which organisms go through the sleep-wake cycle, characterized by a 24-hour period that includes variations in physiological functions such as body temperature, sleep, physical activity, mood and cognition.

There are different sleep patterns and times for performing daily activities. Chronotype is a terminology that refers to the individual expression of circadian rhythmicity, a factor that is related to preferences for sleep time and duration, diet, and physical activity patterns, including exercise. Chronotype can be classified as: morning, intermediate, and evening. Based on this information, the circadian rhythm has been suggested as an influencer on responses to physical training. This biological clock can be impaired in people with metabolic disorders, such as obesity, while physical training can help regulate this clock. Several studies in humans and rodents have revealed that variables such as skeletal muscle strength and capacity demonstrate significant differences throughout the day. Therefore, this study hypothesizes that combined physical training, in the evening (NOT), compared to the morning (MAT), will cause more marked physiological adaptations, improving metabolic control, in female mice and women with obesity.

Thus, the general objective of the study will be to evaluate the effects of Combined Physical Training (CPT) performed in the morning versus evening on the remodeling of muscle and adipose tissue, metabolism and physical performance in women with obesity.

While the specific objectives:

1. To evaluate in women with obesity, before, during and after the intervention with morning TFC and evening TFC: 1.1. Body composition and body thermography; 1.2. Resting energy expenditure and oxidation of substrates (carbohydrates and lipids); 1.3. Food consumption; 1.4. Physical performance (muscular and aerobic strength); 1.5. Behavioral measures of sleep (sleep duration; sleep latency; habitual sleep duration and efficiency; circadian sleep quality and typology; daytime sleepiness); 1.6. Plasma metabolome by UPLC-MS. 1.7. Hormone levels in peripheral blood (cortisol, melatonin, corticotropin-releasing hormone - CRH, and adrenocorticotropic hormone - ACTH); 1.8. The level and phase of gene expression of the circadian cycle in peripheral blood (BMAL1, CLOCK, Cry1 and 2, Per1-3) and of energy metabolism in peripheral blood (PGC-1α, PPARγ, PPARα, NR1D1); 1.9. Verify the concentration of anti- and pro-inflammatory cytokines and myokines in peripheral blood (IL-1, IL-6, TNF-α, IL-10, IL-15 irisin, adiponectin, BNDF);

Therefore, this is an exploratory, prospective and longitudinal study, which will be carried out at the Laboratory of Research in Metabolism, Physiology and Physical Exercise of the State University of Minas Gerais, Divinópolis unit, Minas Gerais, Brazil. The sample size calculation was performed based on an equation. To perform the calculation, the chosen variable was physical performance, and data from the work of Bruggisser, was used as a source. The significance level adopted was 5%, the test power was 90%, the standard deviation was 0.80 W/kg and the difference to be detected was 0.51 W/kg. The calculation showed the need for 10 participants in each experimental group, assuming a possible loss of 20% throughout the study, the sample will consist of 12 participants per group, totaling 36 individuals of the biological female sex.

The study will last a total of 12 weeks. After verifying whether the people who have shown interest meet the inclusion criteria, they will undergo a period of anthropometric assessments, body composition, energy metabolism, blood sample collection, familiarization with the training protocol and physical tests, 2 weeks before the TFC intervention. After the TFC intervention, which will last 8 weeks and be performed 3 times a week, the same series of assessments and physical tests will be repeated for 2 weeks. Also, throughout the study, food consumption will be monitored through 24-hour recalls, and participants will be advised not to change their usual diet.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • MG
      • Divinópolis, MG, Brazil, 35500010
        • Laboratory of Research Metabolism, Physiology and Exercise

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women aged between 20 and 45 years
  • not practicing physical exercise
  • body mass index between 30 and 39.9 kg/m²
  • without any positive response when filling out the risk stratification questionnaire

Exclusion Criteria:

  • Cardiovascular comorbidity
  • joint and neuromuscular injuries
  • diseases that affect visual and auditory functions
  • disorders related to the sleep and wake cycle
  • dependent on the use of psychoactive drugs
  • drug treatment that influences sleep
  • drug weight loss treatments
  • previous bariatric surgery
  • illness during the project period
  • night shift workers
  • attendance of 90% of the intervention with physical training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control
Women who will be assessed in the morning period from 7 am to 10 am and in the evening from 6 pm to 9 pm, who will not receive intervention with combined physical training.
Group of women who will not receive intervention with combined physical training, but will be evaluated before and after 8 weeks, and monitored, without any intervention with physical exercise.
Experimental: Morning Physical Training
Women who will perform the combined physical training at morning from 7 am to 10 am.
A group of women who will perform the combined physical training (CPT) at morning from 7 am to 10 am, for 8 weeks and a frequency of 3 times per week (total = 24 sessions) with strength exercises and aerobic endurance exercises, performed in combination. In weeks 1 and 2, the strength training protocol will be performed with 2 sets of 16-20 maximum repetitions (RM). During weeks 3 to 5 with 12-16 RM. In weeks 6 to 8, 4 sets of 8-12 RM, with rests of 60s (weeks 1 and 2), 90s (weeks 3 to 5) and 105s (weeks 6 to 8). The minimum frequency is 90% of the training sessions. With the aerobic resistance protocol, there will be a gradual progression of the duration (volume) of the exercise (from 20 to 30 minutes per training session) and intensity (from 65% to 75% of HRres). In the first two weeks of training, participants will train at an intensity of 65% of HRres during weeks 3 to 5, at 70% of HRres in weeks 6 to 8, the intensity will reach 75% of HRres.
Experimental: Night Physical Training
Women who will perform the combined physical training at night from 6 pm to 9 pm.
A group of women who will perform the combined physical training (CPT) at morning from 6 pm to 9 pm, for 8 weeks and a frequency of 3 times per week (total = 24 sessions) with strength exercises and aerobic endurance exercises, performed in combination. In weeks 1 and 2, the strength training protocol will be performed with 2 sets of 16-20 maximum repetitions (RM). During weeks 3 to 5 with 12-16 RM. In weeks 6 to 8, 4 sets of 8-12 RM, with rests of 60s (weeks 1 and 2), 90s (weeks 3 to 5) and 105s (weeks 6 to 8). The minimum frequency is 90% of the training sessions. With the aerobic resistance protocol, there will be a gradual progression of the duration (volume) of the exercise (from 20 to 30 minutes per training session) and intensity (from 65% to 75% of HRres). In the first two weeks of training, participants will train at an intensity of 65% of HRres during weeks 3 to 5, at 70% of HRres in weeks 6 to 8, the intensity will reach 75% of HRres.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolomics
Time Frame: 7 months
Blood samples will be collected before and after the eight weeks of intervention with combined physical training for analysis of the plasma metabolome, using the UPLC-MS metabolomics method.
7 months
Plasma glucose
Time Frame: 4 months
Blood samples will be collected before and after the eight weeks of intervention with combined physical training for analysis of the concentration of the plasma Glucose.
4 months
Lipid profile
Time Frame: 4 months
Blood samples will be collected before and after the eight weeks of intervention with combined physical training for analysis of the concentration of the Lipid profile: total cholesterol, triglycerides and lipoproteins.
4 months
Hormones
Time Frame: 4 months
Blood samples will be collected before and after the eight weeks of intervention with combined physical training for analysis of the concentration of the hormones: cortisol, melatonin, corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH), insulin, growth hormone;
4 months
Genes expression
Time Frame: 4 months

Blood samples will be collected before and after the eight weeks of intervention with combined physical training for analysis of the concentration of the gene expression:

  • Level and phase of gene expression and circadian rhythm protein: BMAL1, Per1 and RevErba;
  • Gene expression of energy metabolism: PGC-1a, PPARa, NR1D1
4 months
Cytokines
Time Frame: 4 months
Blood samples will be collected before and after the eight weeks of intervention with combined physical training for analysis of the concentration of the Anti-inflammatory cytokines and myokines: IL-1, IL-6, IL-15, irisin, BNDF;
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thermographic response
Time Frame: 3 months
Tissue temperature will be assessed by a themographic camera, before and after the eight weeks of intervention with combined physical training, with the following interest regions: supraclavicular, subscapular, abdomen, forehead, hand and back.
3 months
Indirect calorimetry
Time Frame: 3 months

Indirect Calorimetry: The use of gas analyzers will allow the measurement of oxygen consumption, and carbon dioxid production to calculate the resting metabolic rate, carbohydrate and lipids oxidation, and peak oxygen consumption.

They will be evaluated before and after the intervention with combined physical training.

3 months
anthropometric measurements
Time Frame: 3 months
body weight (kg) and body height (cm) will be assessed to determine the body mass index, before and after the intervention.
3 months
Multifrequency bioimpedance
Time Frame: 3 months
will be assessed using multifrequency tetrapolar bioelectrical impedance (BIA) (1-1000 kHz) to measure body composition (body fat, fat-free mass, muscle mass, body water), before and after the intervention.
3 months
Dual x-ray absorptiometry
Time Frame: 3 months
The mineral bone content, composition of free fat mass, lean mass, muscle mass, fat mass will all be assessed by dual x-ray absorptiometry, before and after the intervention.
3 months
cardiopulmonary fitness
Time Frame: 3 months

The cardiopulmonary fitness will be evaluated in two days, being one at morning (7-10 am) and another at night (6-9 pm), before and after the intervention.

An ergometric test with indirect calorimetry will be performed to analyze maximum oxygen consumption.

3 months
Strength performance
Time Frame: 3 months
The strength performance will be evaluated in two days by 1RM test, being one at morning (7-10 am) and another at night (6-9 pm), before and after the intervention.
3 months
Blood pressure monitoring
Time Frame: 3 month
The blood pressure ( systolic and diastolic) will be evaluated during intervention, by sphygmomanometer and stethoscope.
3 month
Sleep Quality Index
Time Frame: 3 months

Participants will be assessed using the following questionnaires Pittsburgh Sleep Quality Index, before and after intervention.

The instrument is divided into seven components on sleep subjectivity of the current month

3 months
Excessive daytime sleepiness
Time Frame: 3 months
Participants will be assessed, before and after intervention, using the following questionnaire Epwort Sleepiness, instrument to assess excessive daytime sleepiness (EDS). Measurements above 10 on the Epworth scale are associated with sleep disturbances.
3 months
Morningness-Eveningness questionnaire
Time Frame: 3 months
Participants will be assessed using the following questionnaire, before and after intervention, by Morningness-Eveningness, to determine participants' preferences.
3 months
Behavioral of sleep
Time Frame: 3 months
Participants will be assessed using an actigraph (Condor Instruments) will be used, which is a wristwatch specifically designed to accurately measure activity, light and temperature on the wrist and is the ideal tool for researchers and physicians in the fields of chronobiology and sleep medicine.
3 months
Food intake
Time Frame: 3 months
The food intake standart of each subject will be analyzed by a nutritionist using a 24 hours food recall (24fr) Five Step Multiple Pass method. The full amount of 24fr will be thirteen (13) for each participant, being three (3) on the first week of the study, two (2) on the physical test week pre-intervention, three (3) during the intervention, two (2) on the physical test week post-intervention, and three (3) on the last week of the study.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2024

Primary Completion (Estimated)

December 20, 2024

Study Completion (Estimated)

July 31, 2025

Study Registration Dates

First Submitted

September 11, 2024

First Submitted That Met QC Criteria

September 14, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

December 13, 2024

Last Update Submitted That Met QC Criteria

December 9, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CAAE-59429722.1.0000.5115
  • APQ-02960-22 (Other Grant/Funding Number: FAPEMIG-Minas Gerais State Research Support Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity and Overweight

Clinical Trials on No intervention

Subscribe